Internal Medicine, Infectious Disease · Fort Worth, TX
NPI
1346404993
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1500 S Main St
Fort Worth, TX, 76104
Phone (817) 702-3431
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,050 services
Medicare patients, 2024
219
Average age 72
Drug cost, 2024
$5.5M
4,854 prescriptions
Company payments, 2025
$859
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vitaly Golub was code 99232 (hospital e&m - subsequent), 597 times for 140 patients. In total Vitaly Golub billed 1,050 services in 13 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 597 | 140 | $60.84 | $36K |
| 99222 Hospital E&M - Initial | Facility | 133 | 99 | $100.72 | $13K |
| 99214 Office E&M - Established | Facility | 131 | 45 | $63.70 | $8,344 |
| 99231 Hospital E&M - Subsequent | Facility | 89 | 48 | $38.14 | $3,394 |
| 99214 Office E&M - Established | Office | 32 | 14 | $95.63 | $3,060 |
| 99223 Hospital E&M - Initial | Facility | 16 | 15 | $133.97 | $2,143 |
By year: 2022 $67K for 1,004 services; 2023 $72K for 1,053 services; 2024 $70K for 1,050 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vitaly Golub prescribed most often to Medicare patients was Symtuza (Darunavir/Cob/Emtri/Tenof Alaf), with 414 prescriptions and refills. In total Vitaly Golub wrote 4,854 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 414 | 430 | 49 | $2.0M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 283 | 285 | 39 | $1.2M |
| Tivicay Dolutegravir Sodium | 204 | 210 | 27 | $465K |
| Atorvastatin Calcium Generic | 168 | 432 | 49 | $1,378 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 132 | 152 | 32 | $4,422 |
| Dovato Dolutegravir Sodium/Lamivudine | 131 | 136 | 20 | $378K |
| Gabapentin Generic | 130 | 260 | 43 | $2,747 |
| Rosuvastatin Calcium Generic | 121 | 321 | 36 | $1,816 |
| Pantoprazole Sodium Generic | 97 | 187 | 26 | $740 |
| Descovy Emtricitabine/Tenofov Alafenam | 86 | 90 | 12 | $200K |
| Losartan Potassium Generic | 83 | 245 | 28 | $468 |
| Ozempic Semaglutide | 72 | 100 | 12 | $91K |
| Pifeltro Doravirine | 67 | 75 | Under 11 | $126K |
| Tamsulosin Hcl Generic | 65 | 155 | 16 | $757 |
| Jardiance Empagliflozin | 64 | 140 | 18 | $78K |
Brand drugs: 2,034 claims; generic drugs: 2,790 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vitaly Golub $859 ($859 in general payments such as food, travel and fees) from 7 companies. The largest payer was ViiV Healthcare Company with $206.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.